Cargando…
The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA
PURPOSE: Antibody assays against SARS-CoV-2 are used in sero-epidemiological studies to estimate the proportion of a population with past infection. IgG antibodies against the spike protein (S-IgG) allow no distinction between infection and vaccination. We evaluated the role of anti-nucleocapsid-IgG...
Autores principales: | Paul, Gregor, Strnad, Philipp, Wienand, Oliver, Krause, Ursula, Plecko, Thomas, Effenberger-Klein, Anja, Giel, Katrin Elisabeth, Junne, Florian, Galante-Gottschalk, Annette, Ehehalt, Stefan, Jürgensen, Jan Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159036/ https://www.ncbi.nlm.nih.gov/pubmed/35648370 http://dx.doi.org/10.1007/s15010-022-01830-x |
Ejemplares similares
-
Stress and Depressive and Anxiety Symptoms in the General Population and in SARS-CoV-2-Infected Patients—Findings from a Population-Based Three-Wave Study
por: Wallis, Hannah, et al.
Publicado: (2023) -
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
por: Beavis, Kathleen G., et al.
Publicado: (2020) -
Longitudinal development of depression and anxiety during COVID-19 pandemic in Germany: Findings from a population-based probability sample survey
por: Giel, Katrin E., et al.
Publicado: (2022) -
Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa
por: Gededzha, Maemu P., et al.
Publicado: (2021) -
Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
por: Van Elslande, J., et al.
Publicado: (2020)